Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.1 EX-4.1
- 4.3 EX-4.3
- 4.4 EX-4.4
- 4.5 EX-4.5
- 4.6 EX-4.6
- 4.7 EX-4.7
- 4.8 EX-4.8
- 4.9 EX-4.9
- 4.10 EX-4.10
- 4.11 EX-4.11
- 4.12 EX-4.12
- 4.13 EX-4.13
- 4.14 EX-4.14
- 4.15 EX-4.15
- 4.16 EX-4.16
- 4.17 EX-4.17
- 4.18 EX-4.18
- 4.19 EX-4.19
- 4.20 EX-4.20
- 4.21 EX-4.21
- 4.22 EX-4.22
- 4.23 EX-4.23
- 4.24 EX-4.24
- 4.25 EX-4.25
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 5.4 EX-5.4
- 5.5 EX-5.5
- 5.6 EX-5.6
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 12.1 EX-12.1
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 23.4 EX-23.4
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- CORRESP Corresp
Cadent Medical Communications similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT AUDITORS
We have issued our report dated October 26, 2009, with respect to the financial statements of PharmaNet Development Group, Inc. contained in the Registration Statement. We consent to the use of the aforementioned report in the Registration Statement, and to the use of our name as it appears under the caption “Experts.”
/s/ GRANT THORNTON LLP
Philadelphia, Pennsylvania
October 6, 2014